Generate a tailored SOP for Dr. Gabrielle Agin Liebes. Improve your application with a focused, well-structured draft.
Gabrielle Agin-Liebes is a licensed clinical psychologist and an instructor at Yale School of Medicine. She serves as the lead investigator on a Connecticut state-funded psilocybin trial examining the safety and efficacy of psilocybin therapy in a real-world, transdiagnostic population. Her research, supported by the National Institutes of Health, including the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, combines both quantitative and qualitative methodologies to investigate the psychological mechanisms underlying psychedelic-assisted therapy. She has explored the therapeutic potential of ceremonial plant medicine use in indigenous community settings, particularly in relation to trauma-related disorders. With extensive expertise in treating substance use and trauma disorders, she is certified in psilocybin, MDMA, and ketamine-assisted therapies.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.